Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biosource International -- Ignore unavailable to you. Want to Upgrade?

To: Joe Dancy who wrote (467)	4/23/1998 1:46:00 PM
From: Joe Dancy	Read Replies (2) \| Respond to of 696

Just got off the conference call. Would not be surprised to see a pop in the price this afternoon, better than the 1/16 rise we have seen this morning anyway. Was generally positive. Company said that new products already introduced should start to push revenues up 10-15% a quarter. New products in a hot area will also be introduced shortly that will help near the end of the year. One analyst estimated with the buyback the earnings that we will be looking at will be around 53 cents a share at the end of the year - of course less when you take the average number of shares outstanding over the year and the diluted number - and the company said they could not dispute those estimates - they were close or at least reasonable. Company bought back 2.5 million in stock last quarter, and will continue program. Compared to other companies (competitors) BIOI is selling at about half of where it should considering growth and price earnings valuation. One competitor even has a PE of 130. (Let's see, earning of 50 cents times a PE of 130 gives us a target price of $65 :) - just kidding). Exchange rate going forward should make year to year comparisons a little better (I did not catch the entire discussion here, and management threw in the caveat that no-one knows where exchange rates are going - so take the comment with a grain of salt). Like what I heard. Joe